Clinical Trial: Clinical Study Evaluating Pharmacogenomics-informed Pharmacotherapy Versus Dosing as Usual in Psychiatric Disorders
Study Status: Completed
Recruit Status: RECRUITING
Condition: Mood Disorders
Study Type: INTERVENTIONAL
Official Title: A New Intervention for Implementation of Pharmacogenetics in Psychiatry
Brief Summary:
A 24-week, patient- and rater-blinded, two-arm, parallel-group controlled, and multi-centre randomized clinical trial (RCT) to establish the benefits of pharmacogenetics-informed pharmacotherapy versus dosing as usual (DAU) in psychiatric patients suffering from mood, anxiety, or psychotic disorders.
Read more